Galera Submits New Drug Application for Avasopasem for Severe Oral Mucositis

MALVERN, Pa., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news